Voloridge Investment Management’s Health Catalyst HCAT Stock Holding History

Voloridge Investment Management’s Portfolio HCAT Stock Details HCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-94,674	Closed	-$1.18M	–	1476
2023 Q2	$1.18M	Sell	94,674 -134,686	-59%	-$1.6M	0.01%	1088
2023 Q1	$2.68M	Sell	229,360 -203,529	-47%	-$2.59M	0.01%	896
2022 Q4	$4.6M	Buy	432,889 +173,490	+67%	+$1.67M	0.03%	669
2022 Q3	$2.52M	Buy	+259,399	New	+$3.43M	0.01%	911
2022 Q1	–	Sell	-14,541	Closed	-$576K	–	1507
2021 Q4	$576K	Sell	14,541 -14,473	-50%	-$660K	﹤0.01%	1388
2021 Q3	$1.45M	Buy	29,014 +13,125	+83%	+$716K	0.01%	1160
2021 Q2	$882K	Buy	15,889 +863	+6%	+$46K	0.01%	1296
2021 Q1	$703K	Buy	+15,026	New	+$728K	0.01%	1120

Other funds holding HCAT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Daventry Group New York $133M AUM 32.28% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Voloridge Investment Management's HCAT Position: Q3 2023 in Review

Voloridge Investment Management sold out of Health Catalyst (HCAT) in Q3 2023, closing a stake of 94,674 shares — an estimated $1.18M sold.

Voloridge Investment Management first reported a position in HCAT in Q1 2021 and held it in 8 quarters. The position peaked at $4.6M in Q4 2022. 159 funds tracked by Wall St. Rank hold HCAT as of Q3 2023.

Voloridge Investment Management reported no remaining Health Catalyst position as of Q3 2023 after selling out during the quarter.
Voloridge Investment Management sold 94,674 Health Catalyst shares in Q3 2023, an estimated $1.18M.
Voloridge Investment Management first reported a position in Health Catalyst in Q1 2021 and held it in 8 quarters.
Voloridge Investment Management's Health Catalyst position peaked at $4.6M in Q4 2022.
159 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2023.

Based on Voloridge Investment Management's 13F filing for Q3 2023, filed 14 Nov 2023.